All atropine Articles
-
9Patient CommunicationEducating Health Care Professionals about Myopia Management Gets More Patients Treatment
September 16, 2024 By Y. Shira Kresch, OD, MS, FAAO We want our patients to be educated about the risks of untreated...
-
8Research ReviewCan We Differentiate Between ‘Responders’ and ‘Non-Responders’ to Myopia Control Interventions?
September 16, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In their article “Can we really distinguish ‘responders’ from ‘non-responders’ to...
-
269Research ReviewAtropine Monotherapy vs. Combined with MiSight 1 Day Contact Lenses
September 3, 2024 By Rumeysa Doger, BBioMed, OD Topical atropine is among the myopia treatments with proven efficacy, though treatment effect, side...
-
1.2KEditor’s PerspectiveCombination Therapy in Myopia Management
August 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE To determine the success of any juvenile-onset myopia intervention, it is...
-
90ClinicalWhich Myopic Children Will Benefit From Low-Dose Atropine?
August 1, 2024 By Catherine Tay, BOptom, GradCertPublicHealth Environmental factors, genetic factors, and patient characteristics are important determinants that may help guide...
-
695Latest Myopia NewsSydnexis Names Perry J. Sternberg CEO
July 16, 2024 DEL MAR, Calif. — Sydnexis has officially named a new Chief Executive Officer and member of the Board of...
-
806Research ReviewSignificant Advances in Myopia Control Strategies for Children
June 17, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE While myopia can be optically corrected, such corrections cannot address the...
-
749Research ReviewEfficacy of 0.01% Atropine Eye Drops for Myopia Control in European Children
June 3, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
-
394Latest Myopia NewsVyluma Receives EU Marketing Application Authorization for Low-Dose Atropine NVK002
May 29, 2024 BRIDGEWATER, N.J. — Vyluma announced it has received approval from the European Medicines Agency (EMA) of its Marketing Authorization...
-
592PodcastsA Distant Mirror: How Is China Addressing Myopia?
May 6, 2024 While in Shanghai to attend the “Frontier in Vision Science Summit — Myopia Research,” Review of Myopia Management took...
-
786Research ReviewSeeing Beyond Efficacy
May 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The management of juvenile-onset myopia is a critical public health issue,...
-
681Research ReviewFive-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study
April 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Topical low-concentration atropine eye drops to help slow the progression of...
-
284ClinicalLow-dose Atropine and OrthoK: What Does the Evidence Say?
April 1, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
-
1.1KResearch ReviewCompounded 0.01% Atropine — What’s in the Bottle?
February 1, 2024 By Luke Seesink, BApplSci According to this study, there is significant variability in the quality and consistency of compounded...
-
658Latest Myopia NewsEyenovia Regains Rights to MicroPine Atropine Spray in U.S. and Canada
January 18, 2024 NEW YORK — Eyenovia has regained the rights to MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by...
-
737Research ReviewPrevention of Myopia Shift and Myopia Onset Using 0.01% Atropine in Pre-Myopic Children
January 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE According to the International Myopia Institute (IMI) white paper Defining and...
-
1.6KClinicalAffirming the Importance of Short-Term Trials Complemented with Long-Term Follow-Up
December 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Clinical trial results of topical atropine eye drops for childhood myopia...
-
1.3KClinicalObstacles with Compounded Low-Dose Atropine
sponsored content November 1, 2023 By Erin S. Tomiyama, OD, PhD, FAAO Most compounding pharmacies are small and do not have the...
-
970Research ReviewEffect of Topical Low-Dose Atropine on Binocular Vision and Accommodation
August 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Eye care professionals frequently prescribe topical low-dose atropine to slow myopic...
-
1.2KResearch ReviewCombination Therapy for Myopia Progression Control
July 5, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Most published myopia clinical trials study a single intervention versus control,...
-
1.6KResearch ReviewCHAMP Study Three-Year Results
June 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In a new study recently published in JAMA Ophthalmology, a novel preservative-free...
-
1.2KLatest Myopia NewsFDA Accepts Vyluma’s New Drug Application for NVK002 Atropine
June 6, 2023 BRIDGEWATER, N.J. — The U.S. Food and Drug Administration (FDA) has accepted Vyluma’s new drug application (NDA) for its...
-
1.4KLatest Myopia NewsMyopia Research Highlights from the ARVO 2023 Meeting
May 3, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE A gold mine for cutting-edge myopia research, the ARVO Meeting, held...
-
1.6KLatest Myopia NewsWSPOS Releases Myopia Consensus Statement 2023
DUBLIN – The World Society of Paediatric Ophthalmology and Strabismus has released its Myopia Consensus Statement 2023. The document details the interventions...
-
1.1KResearch ReviewPotentially Delaying the Onset of Myopia in Children
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Low concentration (0.01% to 0.05%) atropine effectively slows myopia progression in...
-
2.1KClinicalShould Atropine Be Prescribed for All Children Wearing OrthoK?
March 1, 2023 By Peter (Zhi) Chen, MD, PhD, Fudan University Eye and ENT Hospital, Shanghai, China Low-concentration atropine is needed only...
-
1.0KLatest Myopia NewsHarrow’s Compounded Atropine Now Available Through ImprimisRx
February 15, 2023 NASHVILLE, Tenn. — U.S. pharmaceutical company Harrow has released its compounded, patent-pending formulas of low-dose atropine. Eye care professionals...